Provision of EAC - Lot 4a (Clinical and Economic Evidence Assessment - additional capacity)
Estimated value
£48k
Awarded value
£48k
Suppliers
1
Lots
1
Published
20 Jul 2023
Description
NICE is seeking to commission external assessment centres (EACs) which will provide a range of health technology assessment (HTA) services to support its technology evaluation programmes and related activities (see above). Suppliers must be able to provide all services within Lots 1 and 2, for Lot 3, 3a or 3b to bid for that Lot. Suppliers need to be able to provide only the services within a work package to bid for any of the work packages within Lot 4. Suppliers can bid for one or more Lots. NICE will consider bids from multidisciplinary centres with knowledge and expertise in health technology assessment, enhanced for Lots 1 and 3 by a close association with frontline clinical services in areas related to medical technologies such as imaging or in vitro diagnostics. Suppliers intending to provide services in Lot 2 will have significant expertise and experience of advanced HTA methods and be able to provide the service in relation to pharmaceuticals, medical, digital and diagnostic technologies. NICE will consider proposals from consortia or networks of organisations meeting the selection criteria and encourages potential suppliers to explore collaborations that will result in the offer of a comprehensive range of services. Apply via the NICE EAC Framework 22-25.
Scope
- Reference
- NICE EACFA 22-25 - 113
- Total value
- £48,092.45 excluding VAT
- Commercial tool
- Standalone contract
- Contract dates
- 09 Jul 2023 to 21 Sept 2023
- CPV classifications
- 73000000
- Particular suitability
- Small and medium-sized enterprises (SME)
Submission & procedure
- Submission deadline
- 30 Dec 2021, 5:00 pm
Award details
Awarded supplier(s), contract period and value as published in the award notice.
Awarded value
£48k
Award date
03 Jul 2023
Contract start
09 Jul 2023
Contract end
21 Sept 2023